EUDA Health (NASDAQ:EUDA) Stock Price Down 10.1% on Disappointing Earnings

Shares of EUDA Health Holdings Limited (NASDAQ:EUDA) dropped 10.1% on Wednesday following a weaker than expected earnings announcement. The stock traded as low as $14.30 and last traded at $14.30. Approximately 12,340 shares traded hands during trading, a decline of 60% from the average daily volume of 30,642 shares. The stock had previously closed at $15.90.

The company reported ($0.17) EPS for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.57). The firm had revenue of $1.73 million for the quarter, compared to analysts’ expectations of $9.61 million.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of EUDA Health in a report on Wednesday, August 5th. One investment analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $55.00.

EUDA Health Stock Down 10.1%

The firm’s fifty day simple moving average is $15.56 and its 200-day simple moving average is $13.69.

EUDA Health Company Profile

EUDA Health Holdings Limited is a digital health company focused on using technology to improve access to healthcare services. The company operates through subsidiaries and develops digital platforms intended to connect patients with healthcare providers and support the delivery of healthcare services.

Its activities include telemedicine and other technology-enabled healthcare solutions, such as facilitating virtual consultations, healthcare appointments and related services. EUDA has also pursued artificial-intelligence applications in sexual health, including technology designed to support the assessment of certain male sexual-health conditions.

The company is based in Singapore and has focused its operations on the Southeast Asian healthcare market.